Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects

NCT00455247 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT00455247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
January 31, 2012
Enrollment
Not reported
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

digestive cancers